List view / Grid view
6 July 2016 | By Victoria White, Digital Content Producer
Medivation has entered into confidentiality agreements with parties that have expressed interest in exploring a potential transaction to acquire the company...
16 June 2016 | By Victoria White, Digital Content Producer
Results from a Phase I/II study of pidilizumab demonstrated potential clinical benefit in paediatric patients with diffuse intrinsic pontine glioma (DIPG)...
25 May 2016 | By Victoria White, Digital Content Producer
Sanofi says it had 'no choice' but to commence a process to elect eight independent directors who are more open to evaluating Sanofi's takeover proposal...
3 May 2016 | By Victoria White, Digital Content Producer
Medivation’s Board has determined that the proposal from Sanofi to acquire Medivation for $52.50 per share substantially undervalues the company...
28 April 2016 | By Victoria White, Digital Content Producer
Sanofi has made an unsolicited $9.3 billion offer to acquire Medivation, the maker of prostate cancer drug Xtandi...
29 March 2016 | By Victoria White
The ARCHES trial will evaluate the efficacy and safety of enzalutamide with androgen deprivation therapy (ADT) versus placebo with ADT in mHSPC patients...
